Get the Stockscreener App
0.92
0.00%
0.00
Pre-market:
.92
60 Degrees Pharmaceuticals Inc stock is traded at $0.92, with a volume of 13,095.
It is up +0.00% in the last 24 hours and down -15.60% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$0.92
Open:
$0.94
24h Volume:
13,095
Relative Volume:
0.11
Market Cap:
$1.74M
Revenue:
$90,700
Net Income/Loss:
$-3.43M
P/E Ratio:
-0.5656
EPS:
-1.6266
Net Cash Flow:
$-4.65M
1W Performance:
-6.12%
1M Performance:
-15.60%
6M Performance:
-72.52%
1Y Performance:
-87.92%
1-Day Range:
$0.865
$0.94
1-Week Range:
$0.86
$1.0399
52-Week Range:
$0.7015
$18.36
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| SXTP | 0.92 | 1.74M | 90,700 | -3.43M | -4.65M | -1.6266 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals’ (SXTP) Neutral Rating Reaffirmed at HC Wainwright - Defense World
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates - MSN
60 Degrees Pharmaceuticals Reports 164% Sales Surge in Q3 2024, Driven by ARAKODA® Growth - GuruFocus.com
60 Degrees Pharmaceuticals Inc. Warrant (SXTPW) Quarterly 10-Q Report - Quartzy
ARMISTICE CAPITAL, LLC Acquires New Stake in 60 Degrees Pharmace - GuruFocus.com
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results - GlobeNewswire
60 Degrees Pharma Reports 164% Revenue Surge, Doubles ARAKODA® Deliveries in Q3 | SXTP Stock News - StockTitan
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - Nasdaq
60 Degrees Pharmaceuticals secures shareholder nods for key proposals - Investing.com India
60 Degrees Pharmaceuticals secures shareholder nods for key proposals By Investing.com - Investing.com South Africa
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Compugen (CGEN) Stock Surges Amidst Biotech Sector Volatility - GuruFocus.com
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
SEC Form DEF 14A filed by 60 Degrees Pharmaceuticals Inc. - Quantisnow
Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com
Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today? - MSN
SXTP stock plunges to 52-week low, touches $1 mark By Investing.com - Investing.com UK
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today? - MSN
60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug - MSN
60 Degrees Pharmaceuticals launches Arakoda promotional pilot - TipRanks
60 Degrees Pharmaceuticals pilots ARAKODA awareness program By Investing.com - Investing.com South Africa
60 Degrees Pharmaceuticals pilots ARAKODA awareness program - Investing.com
SXTP stock plunges to 52-week low, touches 1.01 USD By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - The Manila Times
Del Taco Leads the Value Pack with New Del's Mucho Meal$™ and the Return of Cookie Butter Shake! - The Manila Times
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02 - StreetInsider.com
K-pop group Fifty Fifty off to strong start with member line-up reboot - The Straits Times
Documented Gang Member Sentenced to Life in Prison for Killing Five People - Harris County District Attorney's Office
Ultraviolette set to export F77 sports bikes to European countries - Business Upturn
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Clinical Trials Arena
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - EIN News
Market Trading Guide: Century Textiles, Jubilant Foodworks among 5 stock recommendations for Friday - The Economic Times
Heavy Buying Alert: Multibagger IT-stock Hits Upper Circuits On September 18; Zooms 69 Per Cent From 52-Week Low! - Dalal Street Investment Journal
100 films to be made in 48 hours - IOL
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World
SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN
60 Degrees Pharmaceuticals announces private placement sale - Investing.com India
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
| FIELD PAUL | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
| DOW GEOFFREY S | President and CEO |
Apr 12 '24 |
Option Exercise |
0.27 |
68,000 |
18,142 |
745,625 |
| DOW GEOFFREY S | President and CEO |
May 16 '24 |
Option Exercise |
0.22 |
17,000 |
3,791 |
762,625 |
| Allen Charles W | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
| DOW GEOFFREY S | President and CEO |
Jan 31 '24 |
Buy |
0.38 |
25,974 |
9,740 |
703,599 |
| XU CHERYL | Director |
Jan 31 '24 |
Buy |
0.38 |
200,000 |
75,000 |
424,934 |
0.69%
6.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):